Lyka Labs Announces Allotment of Equity Shares Following Board Resolution
The Board of Directors of Lyka Labs Limited approved a significant allotment of equity shares through a circular resolution passed on June 12, 2026. This move relates to the Scheme of Amalgamation that was sanctioned by the National Company Law Tribunal, Ahmedabad Bench, following an earlier intimation provided on April 9, 2026.In accordance with the Board's decision, Lyka Labs Limited allotted 4,62,711 Equity Shares, each having a face value of Rs. 10/- (Rupees Ten Only). These shares were granted to shareholders who held equity in Lyka Exports Limited, referred to as the Transferor Company, based on the company's record date of June 04, 2026.
The allotment was made at a ratio of 23 fully paid-up equity shares of Lyka Labs for every 100 fully paid-up equity shares of Rs. 10/- held in the Transferor Company.
Following the completion of this share allotment, the company's financial structure has been updated. The paid-up equity share capital of Lyka Labs increased to Rs. 36,15,27,110/- (Rupees Thirty Six Crores Fifteen Lakhs Twenty Seven Thousand One Hundred and Ten Only). These funds are represented by a total of 3,61,52,711 fully paid-up equity shares, all carrying a face value of Rs. 10/- each.
The newly allotted equity shares will rank pari-passu with the company's existing equity share capital. Lyka Labs has indicated that these combined shares are proposed to be listed and traded on BSE Limited and the National Stock Exchange of India Limited.
LYKALABS Stock Price Movement
Lyka Labs Limited shares closed higher today, gaining 1.45% to settle at ₹69.60. The equity traded within a daily range of ₹68.30 to ₹71.49, with the stock recording 30,718 shares in volume during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.